Furthermore, Webb et al. have shown that reduction of myeloid cells via CSF-1R blockade can also improve the efficiency of chemotherapy in a human neuroblastoma model in T cell-deficient mice, indicating a beneficial effect independent from the adaptive immune response [94]. This evidence concerns the gene CSF1R and neuroblastoma.